Carlos Bacino
Pediatrics · Houston, TXNPI 1053491472
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $36,955 of the $52,867 with a category attached, or 69.9%. Biomarin Pharmaceutical Inc. accounts for 86.2% of it on its own, with 3 other manufacturers making up the rest. Among pediatrics clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $927.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$46K
- Ascendis Pharma Endocrinology Inc$5K
- F. Hoffmann-la Roche AG$2K
- Sanofi$82
Across 378 payments — averaging $10,805 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$2.1M
- Genentech, Inc.$782K
- Ascendis Pharma Endocrinology Inc$379K
- Roche TCRC, Inc.$325K
- Pfizer$232K
- Ionis Pharmaceuticals, Inc.$206K
- plus $13K from 2 others
What the payments were for
- Consulting fees$36,95570%
- Speaking & faculty fees$7,51414%
- Travel & lodging$5,73611%
- Food & beverage$2,0304%
- Education$6321%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 34 | $45,589 |
| Ascendis Pharma Endocrinology Inc | 18 | $5,443 |
| F. Hoffmann-la Roche AG | 4 | $1,753 |
| Sanofi | 1 | $82 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO 1.2mg$7,344
- Vimizim$1,814
- Non-Covered Product$1,753
- Naglazyme$1,498
- Brineura$1,498
- Palynziq$1,498
- Kuvan$1,498
- Yorvipath$110
How this compares
$52,867 in reported general payments places this provider in the 95th percentile of 5,361 pediatrics providers in Texas.
Other pediatrics in Houston
- Pedro PiedraHouston$729K
- Vernon SuttonHouston$90K
- Farida AbidHouston$50K
- Lindsay CameronHouston$32K
- Juan Torres SanchezHouston$31K
- Martin YudovichHouston$24K
- Raegan HuntHouston$23K
- Michael PickettHouston$14K
- Lara LeonhardtHouston$10K
- Autumn AtkinsonHouston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.